secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001437749-24-007467
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia fails to regain Nasdaq compliance; delisting hearings requested
-------------------------------------------------------------------------

- Nasdaq determined BioCardia failed to meet $35M MVLS requirement by March 4, 2024.
- Also failed to meet minimum bid price of $1.00 by March 11, 2024.
- Company requested hearing by March 13, 2024, which stays suspension pending panel decision.
- No assurance of continued listing; delisting could impair capital raising and stock liquidity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774924007467/0001437749-24-007467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774924007467/bcda20240312c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-007467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer